For: | Tan SY, Wang JY, Shen L, Luo HS, Shen ZX. Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma. World J Gastroenterol 2007; 13(14): 2108-2112 [PMID: 17465457 DOI: 10.3748/wjg.v13.i14.2108] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i14/2108.htm |
Number | Citing Articles |
1 |
Tasuku Matsuoka, Masakazu Yashiro. Molecular Insight into Gastric Cancer Invasion—Current Status and Future Directions. Cancers 2023; 16(1): 54 doi: 10.3390/cancers16010054
|
2 |
Barbara Mroczko, Magdalena Groblewska, Marta Łukaszewicz-Zając, Roman Bandurski, Bogusław Kędra, Maciej Szmitkowski. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients. Clinical Chemistry and Laboratory Medicine 2009; 47(9) doi: 10.1515/CCLM.2009.253
|
3 |
Marta Łukaszewicz-Zając, Barbara Mroczko, Maciej Szmitkowski. Gastric cancer — The role of matrix metalloproteinases in tumor progression. Clinica Chimica Acta 2011; 412(19-20): 1725 doi: 10.1016/j.cca.2011.06.003
|
4 |
Simone Mocellin, Sandro Pasquali. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database of Systematic Reviews 2015; 2015(2) doi: 10.1002/14651858.CD009944.pub2
|
5 |
Barbara Mroczko, Marta Łukaszewicz-Zajac, Katarzyna Guzińska-Ustymowicz, Mariusz Gryko, Jolanta Czyzewska, Andrzej Kemona, Bogusław Kedra, Maciej Szmitkowski. Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in gastric cancer.. Folia Histochemica et Cytobiologica 2010; 47(3) doi: 10.2478/v10042-009-0070-7
|
6 |
Roberta Cardoso, Natalie Coburn, Rajini Seevaratnam, Rinku Sutradhar, Laercio Gomes Lourenco, Alyson Mahar, Calvin Law, Elaine Yong, Jill Tinmouth. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer 2012; 15(S1): 19 doi: 10.1007/s10120-011-0115-4
|
7 |
Pia Vihinen, Risto Ala-aho, Veli-Matti Kähäri. Diagnostic and prognostic role of matrix metalloproteases in cancer. Expert Opinion on Medical Diagnostics 2008; 2(9): 1025 doi: 10.1517/17530059.2.9.1025
|
8 |
Simone Mocellin, Alberto Marchet, Donato Nitti. EUS for the staging of gastric cancer: a meta-analysis. Gastrointestinal Endoscopy 2011; 73(6): 1122 doi: 10.1016/j.gie.2011.01.030
|
9 |
SU-ZUAN CHEN, HUAI-QI YAO, SEN-ZHI ZHU, QIU-YUAN LI, GUANG-HUA GUO, JING YU. Expression levels of matrix metalloproteinase-9 in human gastric carcinoma. Oncology Letters 2015; 9(2): 915 doi: 10.3892/ol.2014.2768
|
10 |
Sugreev Verma, Kousik Kesh, Arnab Gupta, Snehasikta Swarnakar. An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer Risk. Asian Pacific Journal of Cancer Prevention 2015; 16(17): 7393 doi: 10.7314/APJCP.2015.16.17.7393
|
11 |
Robert Michael Kwee, Thomas Christian Kwee. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer 2009; 12(1): 6 doi: 10.1007/s10120-008-0492-5
|
12 |
M Łukaszewicz-Zając, B Mroczko, K Guzińska-Ustymowicz, A Pryczynicz, M Gryko, A Kemona, B Kędra, M Szmitkowski. Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients. Advances in Medical Sciences 2013; 58(2): 235 doi: 10.2478/ams-2013-0018
|